$44.69
-0.20-0.43%
Last update: Sep 4, 8:04 AM
UroGen Pharma Ltd
URGNNASDAQ
UroGen Pharma Earnings & Forecasts
UroGen Pharma (URGN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
UroGen Pharma Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.31 | $-0.50 | $-0.57 | $-0.70 |
| Actual | $-0.28 | $-0.47 | $-0.54 | $-0.69 |
| Surprise | +9.68% | +6.00% | +5.26% | +1.43% |
| Revenue | ||||
| Estimate | $62.1M | $44.6M | $38.2M | $31.9M |
| Actual | $72.5M | $51.0M | $37.8M | $27.5M |
| Surprise | +16.7% | +14.3% | -0.88% | -13.7% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.15 | $0.32 | $0.15 | $0.26 |
| Revenue | ||||
| Consensus | $90.2M | $107.3M | — | — |
